Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications

被引:411
作者
Abel, Erika L. [1 ]
Angel, Joe M. [1 ]
Kiguchi, Kaoru [1 ]
DiGiovanni, John [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA
关键词
SQUAMOUS-CELL CARCINOMA; ENHANCES MALIGNANT PROGRESSION; KERATINOCYTE STEM-CELLS; HARVEY-RAS GENE; TUMOR PROMOTION; SENCAR MICE; EPIDERMAL-KERATINOCYTES; 2-STAGE CARCINOGENESIS; C57BL/6; MICE; CYCLOOXYGENASE-2; OVEREXPRESSION;
D O I
10.1038/nprot.2009.120
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
For more than 60 years, the chemical induction of tumors in mouse skin has been used to study mechanisms of epithelial carcinogenesis and evaluate modifying factors. In the traditional two-stage skin carcinogenesis model, the initiation phase is accomplished by the application of a sub-carcinogenic dose of a carcinogen. Subsequently, tumor development is elicited by repeated treatment with a tumor-promoting agent. The initiation protocol can be completed within 1-3 h depending on the number of mice used; whereas the promotion phase requires twice weekly treatments (1-2 h) and once weekly tumor palpation (1-2 h) for the duration of the study. Using the protocol described here, a highly reproducible papilloma burden is expected within 10-20 weeks with progression of a portion of the tumors to squamous cell carcinomas within 20-50 weeks. In contrast to complete skin carcinogenesis, the two-stage model allows for greater yield of premalignant lesions, as well as separation of the initiation and promotion phases.
引用
收藏
页码:1350 / 1362
页数:13
相关论文
共 135 条
[21]   Sequential down-regulation of E-cadherin with squamous cell carcinoma progression:: Loss of E-cadherin via a prostaglandin E2-EP2-dependent posttranslational mechanism [J].
Brouxhon, Sabine ;
Kyrkanides, Stephanos ;
O'Banion, M. Kerry ;
Johnson, Renee ;
Pearce, David A. ;
Centola, Gina M. ;
Miller, Jen-nie H. ;
McGrath, Kieran H. ;
Erdle, Brandon ;
Scott, Glynis ;
Schneider, Sandra ;
VanBuskirk, JoAnne ;
Pentland, Alice P. .
CANCER RESEARCH, 2007, 67 (16) :7654-7664
[22]   The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted [J].
Brown, K ;
Strathdee, D ;
Bryson, S ;
Lambie, W ;
Balmain, A .
CURRENT BIOLOGY, 1998, 8 (09) :516-524
[23]   CARCINOGEN-INDUCED MUTATIONS IN THE MOUSE C-HA-RAS GENE PROVIDE EVIDENCE OF MULTIPLE PATHWAYS FOR TUMOR PROGRESSION [J].
BROWN, K ;
BUCHMANN, A ;
BALMAIN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :538-542
[24]  
Casanova ML, 2002, CANCER RES, V62, P3402
[25]   CHANGES IN KERATIN EXPRESSION DURING MALIGNANT PROGRESSION OF TRANSFORMED MOUSE EPIDERMAL-KERATINOCYTES [J].
CAULIN, C ;
BAULUZ, C ;
GANDARILLAS, A ;
CANO, A ;
QUINTANILLA, M .
EXPERIMENTAL CELL RESEARCH, 1993, 204 (01) :11-21
[26]   Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis [J].
Chan, K. S. ;
Sano, S. ;
Kataoka, K. ;
Abel, E. ;
Carbajal, S. ;
Beltran, L. ;
Clifford, J. ;
Peavey, M. ;
Shen, J. ;
DiGiovanni, J. .
ONCOGENE, 2008, 27 (08) :1087-1094
[27]   Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis [J].
Chan, KS ;
Sano, S ;
Kiguchi, K ;
Anders, J ;
Komazawa, N ;
Takeda, J ;
DiGiovanni, J .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (05) :720-728
[28]   Genetically engineered mouse models for skin research: Taking the next step [J].
Chen, Jiang ;
Roop, Dennis R. .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2008, 52 (01) :1-12
[29]  
CHIBA M, 1986, CANCER RES, V46, P259
[30]   ANEUPLOIDY, AN EARLY EVENT IN MOUSE SKIN TUMOR-DEVELOPMENT [J].
CONTI, CJ ;
ALDAZ, CM ;
OCONNELL, J ;
KLEINSZANTO, AJP ;
SLAGA, TJ .
CARCINOGENESIS, 1986, 7 (11) :1845-1848